USC scientists identify promising new target for Alzheimer’s-linked brain inflammation

A multidisciplinary team, including NGP Faculty Hussein Yassine, has developed a selective compound that inhibits an enzyme tied to inflammation in people at genetic risk for Alzheimer’s — while preserving normal brain function and crossing the blood-brain barrier. Their research was just published in the Nature publication npj Drug Discovery.

Click Here for the Full Article (Source: USC Today)